Andere Sprachen SomnoMed Limited

Aktien

A0B7QA

AU000000SOM1

SOM

Medizinische Versorgung

Markt geschlossen - Australian S.E. Andere Börsenplätze 07:19:26 10.06.2026			% 5 Tage	Veränd. 1. Jan.
0,5800 ^AUD	-1,69 %		-3,33 %	-24,92 %

27.02.	SomnoMed Limited, H1 2026 Earnings Call, Feb 27, 2026
26.02.	SomnoMed Limited veröffentlicht Ergebnisse für das Halbjahr zum 31. Dezember 2025	CI

Andere Sprachen

26.02.	SomnoMed Limited Reports Earnings Results for the Half Year Ended December 31, 2025
26.02.	SomnoMed Limited Reaffirms Earnings Guidance for the Year 2026
26.02.	SomnoMed Limited Announces Management Appointments
20.11.	Somnomed increases investment in managed care infrastructure
20.11.	SomnoMed Limited Increases Investment in Managed Care Infrastructure
30.10.25	Somnomed says Q1 FY26 revenue up 13.5% to A$28.7 million
29.08.25	Morgans rates SOM as Speculative Buy
28.08.25	Somnomed says FY Ebitda AUD 9.2 million
28.08.25	SomnoMed Limited Provides Earnings Guidance for the Fiscal Year 2026
28.08.25	SomnoMed Limited Reports Earnings Results for the Full Year Ended June 30, 2025
29.07.25	Somnomed Ltd posts Q4 FY25 revenue of A$30.1m
30.04.25	Somnomed Posts Q3 FY25 Revenue Of A$27.7 Million
07.04.25	SomnoMed Plans to Absorb Immediate Costs from US Tariff Changes
07.04.25	Somnomed Limited Reiterates Earnings Guidance for the Fy2025
28.02.25	Somnomed Says H1 Revenue AUD 53.7 Million
27.02.25	SomnoMed Limited Maintains Earnings Guidance for the Fiscal Year 2025
27.02.25	SomnoMed Limited Reports Earnings Results for the Half Year Ended December 31, 2024
24.01.25	SomnoMed Fiscal Q2 Revenue Grows 20%, Shares Rise 10%
23.01.25	Somnomed Limited Reports Revenue Results for the Second Quarter Ended December 31, 2024
19.01.25	SomnoMed Limited Appoints Andrew Price as Director
27.11.24	SomnoMed Upgrades Fiscal 2025 Revenue, EBITDA Guidance; Shares Soar 41%
26.11.24	SomnoMed Limited Revises Earnings Guidance for Fiscal Year 2025
26.11.24	SomnoMed Limited Appoints Ye-Fei Guo as Chief Financial Officer, Effective 27 November 2024
07.10.24	Somnomed Wins US FDA Clearance for Sleep Disorder Product; Shares Jump 5%
03.10.24	SomnoMed Limited Announces Board Changes